The eukaryotic cell cycle. Preface.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18368914)

Published in SEB Exp Biol Ser on January 01, 2008

Authors

John Bryant, Dennis Francis

Articles by these authors

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 18.61

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol (2006) 16.25

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med (2002) 7.66

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59

Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol (2005) 4.77

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol (2005) 4.66

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst (2002) 3.99

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet (2004) 3.98

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol (2002) 3.82

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol (2004) 3.82

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. J Natl Cancer Inst (2004) 2.65

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol (2003) 2.34

Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol (2013) 2.32

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer (2002) 2.18

Letrozole after tamoxifen for breast cancer--what is the price of success? N Engl J Med (2003) 1.90

Association of tamoxifen and uterine sarcoma. J Clin Oncol (2002) 1.80

American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol (2003) 1.64

NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann Surg Oncol (2004) 1.56

Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J (2002) 1.22

A WEE1 homologue from Arabidopsis thaliana. Planta (2002) 1.10

Tobacco BY-2 cells expressing fission yeast cdc25 bypass a G2/M block on the cell cycle. Plant J (2005) 0.98

The Arabidopsis 14-3-3 protein, GF14omega, binds to the Schizosaccharomyces pombe Cdc25 phosphatase and rescues checkpoint defects in the rad24- mutant. Planta (2003) 0.91

Arabidopsis T-DNA insertional lines for CDC25 are hypersensitive to hydroxyurea but not to zeocin or salt stress. Ann Bot (2010) 0.90

Expression of the fission yeast cell cycle regulator cdc25 induces de novo shoot formation in tobacco: evidence of a cytokinin-like effect by this mitotic activator. Plant Physiol Biochem (2004) 0.82

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen. J Natl Cancer Inst (2004) 0.81

Genes encoding two essential DNA replication activation proteins, Cdc6 and Mcm3, exhibit very different patterns of expression in the tobacco BY-2 cell cycle. J Exp Bot (2003) 0.81

Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors. Bioorg Med Chem (2007) 0.80

Differential spatial expression of A- and B-type CDKs, and distribution of auxins and cytokinins in the open transverse root apical meristem of Cucurbita maxima. Ann Bot (2010) 0.80

Youth have a new attitude on AIDS, but are they talking about it? Afr J AIDS Res (2006) 0.80

Ketopiperazine-based renin inhibitors: optimization of the "C" ring. Bioorg Med Chem Lett (2006) 0.80

Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors. Bioorg Med Chem Lett (2007) 0.79

Plant WEE1 kinase is cell cycle regulated and removed at mitosis via the 26S proteasome machinery. J Exp Bot (2013) 0.78

The fission yeast mitotic activator cdc25 and sucrose induce early flowering synergistically in the day-neutral Nicotiana tabacum cv. Samsun. New Phytol (2007) 0.78

In tobacco BY-2 cells xyloglucan oligosaccharides alter the expression of genes involved in cell wall metabolism, signalling, stress responses, cell division and transcriptional control. Mol Biol Rep (2014) 0.78

South African life orientation teachers: (not) teaching about sexuality diversity. J Homosex (2014) 0.76

Gene dosage effect of WEE1 on growth and morphogenesis from arabidopsis hypocotyl explants. Ann Bot (2012) 0.76

Perturbation of cytokinin and ethylene-signalling pathways explain the strong rooting phenotype exhibited by Arabidopsis expressing the Schizosaccharomyces pombe mitotic inducer, cdc25. BMC Plant Biol (2012) 0.76

Inhibition of snowshoe hare succinate dehydrogenase activity as a mechanism of deterrence for papyriferic acid in birch. J Chem Ecol (2011) 0.75

Trastuzumab for early breast cancer. Lancet (2006) 0.75

A LEAFY-like gene in the long-day plant, Silene coeli-rosa is dramatically up-regulated in evoked shoot apical meristems but does not complement the Arabidopsis lfy mutant. J Exp Bot (2007) 0.75

Complexity and its implications for health systems implementation. Stud Health Technol Inform (2007) 0.75

Recovery and separation of cell lysate proteins using hydrogels guided by aqueous two-phase extraction principles. Biotechnol Bioeng (2002) 0.75

Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy. Methods Mol Biol (2002) 0.75

Fatty acid elongation is important in the activity of thiocarbamate herbicides and in safening by dichlormid. J Exp Bot (2003) 0.75

Initiation of DNA replication. SEB Exp Biol Ser (2008) 0.75

A yeast mitotic activator sensitises the shoot apical meristem to become floral in day-neutral tobacco. Planta (2013) 0.75

The Internet and the elderly. Med Inform Internet Med (2005) 0.75

Successful systems sustaining change. Stud Health Technol Inform (2007) 0.75

The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors. Bioorg Med Chem (2005) 0.75

Silence, nostalgia, violence, poverty … : what does 'culture' mean for South African sexuality educators? Cult Health Sex (2014) 0.75

Human criteria in health care. Ecum Rev (1973) 0.75